Conquer Cancer Fdn of the American Society of Clinical Oncology
2318 Mill Rd Ste 800, Alexandria, VA · IRS data through FY2024
Revenue, expenses and net assets
Revenue Expenses Net assets
| Tax year | Revenue | Expenses | Net assets |
|---|---|---|---|
| FY2024 | $41,435,619 | $34,781,420 | $108,199,433 |
| FY2023 | $39,096,707 | $33,575,680 | $97,025,871 |
| FY2022 | $33,133,692 | $32,888,928 | $83,685,128 |
| FY2021 | $24,641,302 | $28,405,556 | $99,502,471 |
| FY2020 | $33,042,638 | $25,241,608 | $98,674,085 |
| FY2019 | $30,450,646 | $24,914,594 | $82,469,859 |
| FY2018 | $33,166,990 | $23,884,739 | $70,194,133 |
| FY2017 | $30,027,096 | $24,905,582 | $65,171,551 |
| FY2016 | $24,574,956 | $27,245,874 | $55,519,461 |
| FY2015 | $30,539,108 | $30,071,361 | $57,891,825 |
| FY2014 | $38,677,114 | $21,156,002 | $59,008,925 |
| FY2013 | $24,579,140 | $18,443,237 | $42,039,103 |
| FY2012 | $26,791,312 | $20,747,206 | $35,153,106 |
| FY2011 | $23,972,995 | $20,771,487 | $28,349,482 |
Form 990 filings
The returns filed by Conquer Cancer Fdn of the American Society of Clinical Oncology (EIN 31-1667995), including Form 990 PDFs and e-file data by year, are available in ProPublica's Nonprofit Explorer. The figures on this page come from IRS data files built from those returns.
Where the revenue came from
| Source | Amount | % of revenue |
|---|---|---|
| Contributions & grants | $37,343,075 | 90% |
| Program service revenue | $364,257 | 1% |
| Other revenue | $3,728,287 | 9% |
Where the money was spent
| Category | Amount | % of expenses |
|---|---|---|
| Program services | $23,236,784 | 67% |
| Management & general | $1,640,533 | 5% |
| Fundraising | $9,904,103 | 28% |
What the numbers show
- Contributions & grants made up 90% of total revenue in FY2024.
- Program services accounted for 67% of functional expenses, management & general 5%, and fundraising 28%.
- 67% of functional expenses went to program services in FY2024. That is higher than 12.7% of 157 Medical Research organizations nationwide (too few in VA for a state comparison).
- Net assets covered about 37.3 months of expenses at the end of the reporting year. That puts it in the 75th percentile among 71 Medical Research organizations in VA.
- Total revenue was higher than 98.6% of 72 Medical Research organizations in VA.
- Total revenue rose from $23,972,995 in FY2011 to $41,435,619 in FY2024. Revenue increased in 8 and decreased in 5 of 13 year-over-year comparisons.
- Expenses exceeded revenue in 2 of 14 reported years (FY2016, FY2021).
- Net assets grew from $28,349,482 to $108,199,433 between FY2011 and FY2024.
- Contributions and grants made up 96% of revenue in FY2011 and 90% in FY2024.
- Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity).
Figures compared against other organizations of the same NTEE program area in the same state. See the methodology page for how these are calculated and the guide to reading nonprofit financials for their limits.
About this organization
TO ACCELERATE BREAKTHROUGHS IN LIFESAVING RESEARCH AND EMPOWER PEOPLE EVERYWHERE TO CONQUER CANCER.
IRS status
| Ruling year | 1999 |
| Subsection | 501(c)(3) |
| Classification | Public charity |
| Program area (NTEE) | H113 — Medical Research |
| Donations | Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity). |
Similar organizations
- Commonwealth Foundation for Cancer Research Foundation — Richmond, VA · $25,046,690
- Riverside Research Institute — Fairfax, VA · $286,600,214
Source: Internal Revenue Service — Exempt Organizations Business Master File (downloaded November 4, 2026), Statistics of Income extracts, Form 990 e-file data, Publication 78 and the Automatic Revocation list. Figures are as reported by the organization; IRS processing may adjust them. This is not a charity rating and not tax advice. Confirm deductibility in IRS Tax Exempt Organization Search.
Think something here is wrong or should be removed? Use the contact form — we act on removal requests within 30 days.